What kind of tumors generally show high FDG uptake?

• A. Benign tumors with low activity
• B. Slow-growing tumors
• C. Aggressive tumors with high metabolic rates
• D. Cysts with minimal metabolic activity

Answer: (C)

High FDG uptake in tumors is primarily associated with aggressive tumors that have high metabolic rates. This phenomenon is due to the enhanced glucose uptake and metabolism that characterizes rapidly dividing cancer cells. Positron Emission Tomography (PET) uses fluorodeoxyglucose (FDG), a radiolabeled glucose analog, to visualize areas of high metabolic activity, which often indicates tumor presence.

Aggressive tumors, such as certain types of sarcomas, lymphomas, and carcinomas, typically exhibit this high glycolytic activity because they require more energy to support their rapid growth and proliferation. This increased metabolic rate leads to a greater uptake of FDG, making it an effective imaging tool for identifying and characterizing these malignancies.

In contrast, benign tumors generally exhibit low metabolic activity, and their FDG uptake is usually minimal. Slow-growing tumors may also show reduced FDG uptake because their metabolic requirements are not as high as those of aggressive tumors. Cysts, which are fluid-filled spaces, typically have minimal metabolic activity, resulting in low FDG uptake as well. Therefore, the identification of aggressive tumors through high FDG uptake serves as an important clinical tool in diagnosis and treatment planning.